| Ligand | Protein Symbol | Approved Name | Docking Scores |
Similarity Score |
Best Match | ||
|---|---|---|---|---|---|---|---|
| Model 1 | Model 2 | Model 3 | |||||
| Oxycodone | 5HT1B_HUMAN | 5-hydroxytryptamine receptor 1B | -9.02 | -9.36 | -8.14 | 59.87% | CHEMBL29951 |
| TEST | 5HT1B_HUMAN | 5-hydroxytryptamine receptor 1B | -8.23 | -9.04 | -8.28 | 52.63% | CHEMBL29951 |
| Oxycodone | 5HT2A_HUMAN | 5-hydroxytryptamine receptor 2A | -8.57 | -7.38 | N/A | 60.90% | CHEMBL3695433 |
| TEST | 5HT2A_HUMAN | 5-hydroxytryptamine receptor 2A | -8.82 | -7.97 | N/A | 51.96% | CHEMBL3695438 |
| Oxycodone | 5HT2B_HUMAN | 5-hydroxytryptamine receptor 2B | -8.44 | -8.51 | -8.60 | 58.33% | CHEMBL445106 |
| TEST | 5HT2B_HUMAN | 5-hydroxytryptamine receptor 2B | -8.43 | -8.69 | -8.74 | 51.06% | CHEMBL445106 |
| Oxycodone | 5HT2C_HUMAN | 5-hydroxytryptamine receptor 2C | -7.85 | -9.67 | N/A | 58.33% | CHEMBL445106 |
| TEST | 5HT2C_HUMAN | 5-hydroxytryptamine receptor 2C | -8.41 | -9.00 | N/A | 51.06% | CHEMBL445106 |
| Oxycodone | AA1R_HUMAN | adenosine A1 receptor | -8.75 | -8.51 | -6.84 | 35.88% | CHEMBL1544 |
| TEST | AA1R_HUMAN | adenosine A1 receptor | -7.66 | -8.26 | -4.65 | 29.96% | CHEMBL3317575 |
| Oxycodone | AA2AR_HUMAN | adenosine A2a receptor | -7.44 | -7.35 | -9.34 | 42.25% | CHEMBL541219 |
| TEST | AA2AR_HUMAN | adenosine A2a receptor | -8.62 | -9.48 | -10.40 | 34.24% | CHEMBL559023 |
| Oxycodone | ACES_HUMAN | acetylcholinesterase (Cartwright blood group) | -9.80 | -9.61 | -8.26 | 64.71% | CHEMBL3764305 |
| TEST | ACES_HUMAN | acetylcholinesterase (Cartwright blood group) | -9.76 | -8.85 | -8.78 | 66.01% | CHEMBL569978 |
| Oxycodone | ACE_HUMAN | angiotensin I converting enzyme | -8.57 | -8.46 | -7.63 | 46.15% | CHEMBL58042 |
| TEST | ACE_HUMAN | angiotensin I converting enzyme | -8.53 | -8.74 | -7.71 | 37.12% | CHEMBL1165 |
| Oxycodone | ACHA9_HUMAN | cholinergic receptor nicotinic alpha 9 subunit | -6.73 | N/A | N/A | 27.39% | CHEMBL386114 |
| TEST | ACHA9_HUMAN | cholinergic receptor nicotinic alpha 9 subunit | -7.08 | N/A | N/A | 21.72% | CHEMBL386114 |
| Oxycodone | ACHB2_HUMAN | cholinergic receptor nicotinic beta 2 subunit | -5.68 | -2.98 | -7.00 | N/A | N/A |
| TEST | ACHB2_HUMAN | cholinergic receptor nicotinic beta 2 subunit | -5.44 | -3.29 | -5.96 | N/A | N/A |
| Oxycodone | ACM1_HUMAN | cholinergic receptor muscarinic 1 | -10.32 | 4.58 | N/A | 50.00% | CHEMBL343236 |
| TEST | ACM1_HUMAN | cholinergic receptor muscarinic 1 | -10.02 | 3.46 | N/A | 45.66% | CHEMBL343236 |
| Oxycodone | ACM4_HUMAN | cholinergic receptor muscarinic 4 | -10.21 | -6.87 | N/A | 48.50% | CHEMBL1346 |
| TEST | ACM4_HUMAN | cholinergic receptor muscarinic 4 | -9.37 | -6.22 | N/A | 39.27% | CHEMBL1346 |
| Oxycodone | ADRB2_HUMAN | adrenoceptor beta 2 | -8.33 | -8.50 | -8.83 | 49.08% | CHEMBL1773265 |
| TEST | ADRB2_HUMAN | adrenoceptor beta 2 | -7.41 | -7.50 | -8.85 | 43.26% | CHEMBL513389 |
| Oxycodone | AGTR2_HUMAN | angiotensin II receptor type 2 | -8.32 | -8.29 | -8.18 | 51.50% | CHEMBL154057 |
| TEST | AGTR2_HUMAN | angiotensin II receptor type 2 | -8.15 | -7.81 | -7.80 | 42.67% | CHEMBL154057 |
| Oxycodone | ALDR_HUMAN | aldo-keto reductase family 1 member B | -9.02 | -8.24 | -7.54 | 44.77% | CHEMBL71562 |
| TEST | ALDR_HUMAN | aldo-keto reductase family 1 member B | -7.87 | -6.59 | -7.12 | 32.54% | CHEMBL311679 |
| Oxycodone | AMPN_HUMAN | alanyl aminopeptidase, membrane | -8.11 | -8.58 | -8.55 | 40.10% | CHEMBL1077584 |
| TEST | AMPN_HUMAN | alanyl aminopeptidase, membrane | -8.15 | -8.23 | -8.00 | 33.78% | CHEMBL1782887 |
| Oxycodone | AOFA_HUMAN | monoamine oxidase A | -8.95 | -10.08 | -8.28 | 40.54% | CHEMBL4073457 |
| TEST | AOFA_HUMAN | monoamine oxidase A | -8.66 | -9.39 | -8.25 | 34.30% | CHEMBL4073457 |
| Oxycodone | AOFB_HUMAN | monoamine oxidase B | -10.39 | -8.26 | -8.64 | 42.77% | CHEMBL3288304 |
| TEST | AOFB_HUMAN | monoamine oxidase B | -9.87 | -8.60 | -9.19 | 35.75% | CHEMBL4113794 |
| Oxycodone | BACE1_HUMAN | beta-secretase 1 | -7.34 | -7.75 | -9.18 | 48.58% | CHEMBL3955763 |
| TEST | BACE1_HUMAN | beta-secretase 1 | -6.94 | -7.39 | -8.50 | 43.53% | CHEMBL3955763 |
| Oxycodone | CAH2_HUMAN | carbonic anhydrase 2 | -7.56 | -8.24 | -7.98 | 45.73% | CHEMBL3786651 |
| TEST | CAH2_HUMAN | carbonic anhydrase 2 | -7.53 | -7.29 | -6.77 | 40.44% | CHEMBL3786651 |
| Oxycodone | CASP1_HUMAN | caspase 1 | -7.33 | -7.41 | -6.28 | 45.00% | CHEMBL2371932 |
| TEST | CASP1_HUMAN | caspase 1 | -6.89 | -7.24 | -6.96 | 34.62% | CHEMBL3898379 |
| Oxycodone | CDK5_HUMAN | cyclin dependent kinase 5 | -7.89 | -7.65 | -5.47 | 33.04% | CHEMBL422897 |
| TEST | CDK5_HUMAN | cyclin dependent kinase 5 | -6.44 | -6.87 | -5.18 | 29.55% | CHEMBL422897 |
| Oxycodone | CHLE_HUMAN | butyrylcholinesterase | -9.35 | -9.12 | -9.35 | 46.43% | CHEMBL3410956 |
| TEST | CHLE_HUMAN | butyrylcholinesterase | -9.46 | -9.69 | -9.90 | 43.52% | CHEMBL366411 |
| Oxycodone | CNR1_HUMAN | cannabinoid receptor 1 | -7.59 | -8.42 | -8.55 | 53.46% | CHEMBL228349 |
| TEST | CNR1_HUMAN | cannabinoid receptor 1 | -8.92 | -8.18 | -8.41 | 56.82% | CHEMBL303479 |
| Oxycodone | CNR2_HUMAN | cannabinoid receptor 2 | -8.87 | -9.55 | N/A | 53.16% | CHEMBL223990 |
| TEST | CNR2_HUMAN | cannabinoid receptor 2 | -9.73 | -9.02 | N/A | 56.82% | CHEMBL303479 |
| Oxycodone | COLI_HUMAN | proopiomelanocortin | -8.01 | -8.17 | -7.46 | N/A | N/A |
| TEST | COLI_HUMAN | proopiomelanocortin | -8.00 | -8.20 | -6.57 | N/A | N/A |
| Oxycodone | COMT_HUMAN | catechol-O-methyltransferase | -5.86 | -5.75 | -5.72 | 25.55% | CHEMBL3425740 |
| TEST | COMT_HUMAN | catechol-O-methyltransferase | -6.29 | -6.70 | -5.75 | 22.70% | CHEMBL3819488 |
| Oxycodone | CRP_HUMAN | C-reactive protein | -6.15 | -6.24 | N/A | N/A | N/A |
| TEST | CRP_HUMAN | C-reactive protein | -6.20 | -6.58 | N/A | N/A | N/A |
| Oxycodone | CXCR1_HUMAN | C-X-C motif chemokine receptor 1 | -7.74 | N/A | N/A | 27.64% | CHEMBL490688 |
| TEST | CXCR1_HUMAN | C-X-C motif chemokine receptor 1 | -9.03 | N/A | N/A | 28.19% | CHEMBL490688 |
| Oxycodone | CXCR4_HUMAN | C-X-C motif chemokine receptor 4 | -8.66 | -7.05 | -8.07 | 36.61% | CHEMBL3963508 |
| TEST | CXCR4_HUMAN | C-X-C motif chemokine receptor 4 | -7.80 | -6.47 | -7.22 | 33.92% | CHEMBL2029611 |
| Oxycodone | DRD2_HUMAN | dopamine receptor D2 | -8.66 | N/A | N/A | 61.94% | CHEMBL170976 |
| TEST | DRD2_HUMAN | dopamine receptor D2 | -7.56 | N/A | N/A | 55.49% | CHEMBL170976 |
| Oxycodone | DRD3_HUMAN | dopamine receptor D3 | -8.09 | N/A | N/A | 61.94% | CHEMBL170976 |
| TEST | DRD3_HUMAN | dopamine receptor D3 | -8.83 | N/A | N/A | 55.49% | CHEMBL170976 |
| Oxycodone | DRD4_HUMAN | dopamine receptor D4 | -8.53 | -8.57 | N/A | 52.57% | CHEMBL132261 |
| TEST | DRD4_HUMAN | dopamine receptor D4 | -7.98 | -8.26 | N/A | 47.67% | CHEMBL132261 |
| Oxycodone | EDN1_HUMAN | endothelin 1 | -7.38 | N/A | N/A | N/A | N/A |
| TEST | EDN1_HUMAN | endothelin 1 | -7.23 | N/A | N/A | N/A | N/A |
| Oxycodone | ESR1_HUMAN | estrogen receptor 1 | -7.92 | -8.16 | -8.16 | 52.33% | CHEMBL33890 |
| TEST | ESR1_HUMAN | estrogen receptor 1 | -9.00 | -8.76 | -8.75 | 44.56% | CHEMBL178559 |
| Oxycodone | FABP5_HUMAN | fatty acid binding protein 5 | -8.45 | -6.12 | -6.57 | 33.33% | CHEMBL212860 |
| TEST | FABP5_HUMAN | fatty acid binding protein 5 | -8.76 | -6.97 | -6.27 | 30.54% | CHEMBL437489 |
| Oxycodone | FYN_HUMAN | FYN proto-oncogene, Src family tyrosine kinase | -8.22 | N/A | N/A | 32.29% | CHEMBL432649 |
| TEST | FYN_HUMAN | FYN proto-oncogene, Src family tyrosine kinase | -7.44 | N/A | N/A | 28.72% | CHEMBL221753 |
| Oxycodone | GLRA3_HUMAN | glycine receptor alpha 3 | -9.12 | -8.68 | -8.75 | 25.93% | CHEMBL4070615 |
| Oxycodone | GLRA3_HUMAN | glycine receptor alpha 3 | -9.65 | N/A | N/A | 25.93% | CHEMBL4070615 |
| TEST | GLRA3_HUMAN | glycine receptor alpha 3 | -8.35 | -8.10 | -7.91 | 24.31% | CHEMBL4070615 |
| TEST | GLRA3_HUMAN | glycine receptor alpha 3 | -9.51 | N/A | N/A | 24.31% | CHEMBL4070615 |
| Oxycodone | GRM5_HUMAN | glutamate metabotropic receptor 5 | -10.13 | -2.95 | -5.29 | 39.38% | CHEMBL1289626 |
| TEST | GRM5_HUMAN | glutamate metabotropic receptor 5 | -7.11 | -4.70 | -4.34 | 33.15% | CHEMBL1289626 |
| Oxycodone | HPGDS_HUMAN | hematopoietic prostaglandin D synthase | -7.04 | -7.05 | -6.56 | 24.69% | CHEMBL3698267 |
| TEST | HPGDS_HUMAN | hematopoietic prostaglandin D synthase | -7.22 | -6.78 | -6.30 | 23.72% | CHEMBL3698265 |
| Oxycodone | HRH1_HUMAN | histamine receptor H1 | -2.60 | N/A | N/A | 48.47% | CHEMBL476839 |
| TEST | HRH1_HUMAN | histamine receptor H1 | -4.08 | N/A | N/A | 45.25% | CHEMBL476839 |
| Oxycodone | HYES_HUMAN | epoxide hydrolase 2 | -8.98 | -8.39 | -8.09 | 54.72% | CHEMBL1672128 |
| TEST | HYES_HUMAN | epoxide hydrolase 2 | -8.21 | -8.04 | -8.05 | 42.70% | CHEMBL1672128 |
| Oxycodone | IKKB_HUMAN | inhibitor of nuclear factor kappa B kinase subunit beta | -8.46 | N/A | N/A | 36.95% | CHEMBL184041 |
| TEST | IKKB_HUMAN | inhibitor of nuclear factor kappa B kinase subunit beta | -6.24 | N/A | N/A | 31.51% | CHEMBL1672879 |
| Oxycodone | MDR1_HUMAN | ATP binding cassette subfamily B member 1 | -8.39 | -7.90 | N/A | 74.67% | CHEMBL261048 |
| TEST | MDR1_HUMAN | ATP binding cassette subfamily B member 1 | -8.46 | -7.36 | N/A | 100.00% | CHEMBL70 |
| Oxycodone | MIF_HUMAN | macrophage migration inhibitory factor | -6.02 | -7.40 | -6.57 | 28.08% | CHEMBL1289631 |
| TEST | MIF_HUMAN | macrophage migration inhibitory factor | -5.90 | -6.55 | -6.62 | 30.43% | CHEMBL2375651 |
| Oxycodone | MK01_HUMAN | mitogen-activated protein kinase 1 | -7.99 | -8.51 | -7.32 | 40.23% | CHEMBL3752989 |
| TEST | MK01_HUMAN | mitogen-activated protein kinase 1 | -6.98 | -7.80 | -7.41 | 39.53% | CHEMBL555017 |
| Oxycodone | MK03_HUMAN | mitogen-activated protein kinase 3 | -8.18 | -8.27 | -7.74 | 34.65% | CHEMBL555017 |
| TEST | MK03_HUMAN | mitogen-activated protein kinase 3 | -6.44 | -6.79 | -7.50 | 39.53% | CHEMBL555017 |
| Oxycodone | MTOR_HUMAN | mechanistic target of rapamycin kinase | -9.05 | -9.24 | -8.62 | 38.72% | CHEMBL4074753 |
| TEST | MTOR_HUMAN | mechanistic target of rapamycin kinase | -8.52 | -8.62 | -8.41 | 33.33% | CHEMBL4074753 |
| Oxycodone | NEP_HUMAN | membrane metalloendopeptidase | -7.50 | -7.64 | -7.35 | 49.15% | CHEMBL2062138 |
| TEST | NEP_HUMAN | membrane metalloendopeptidase | -8.18 | -8.44 | -7.97 | 38.24% | CHEMBL2062138 |
| Oxycodone | NK1R_HUMAN | tachykinin receptor 1 | -8.72 | -8.75 | -7.67 | 48.07% | CHEMBL2112368 |
| TEST | NK1R_HUMAN | tachykinin receptor 1 | -8.75 | -7.09 | -7.95 | 45.41% | CHEMBL2114439 |
| Oxycodone | NMDE1_HUMAN | glutamate ionotropic receptor NMDA type subunit 2A | -8.98 | -7.84 | -7.67 | 24.02% | CHEMBL284237 |
| TEST | NMDE1_HUMAN | glutamate ionotropic receptor NMDA type subunit 2A | -7.65 | -7.73 | -7.52 | 25.65% | CHEMBL284237 |
| Oxycodone | NMDE2_HUMAN | glutamate ionotropic receptor NMDA type subunit 2B | -7.46 | -8.03 | -6.69 | 44.37% | CHEMBL1289403 |
| TEST | NMDE2_HUMAN | glutamate ionotropic receptor NMDA type subunit 2B | -7.48 | -9.52 | -6.65 | 39.44% | CHEMBL3357783 |
| Oxycodone | NMDZ1_HUMAN | glutamate ionotropic receptor NMDA type subunit 1 | -7.47 | -7.20 | -7.67 | 22.06% | CHEMBL419399 |
| TEST | NMDZ1_HUMAN | glutamate ionotropic receptor NMDA type subunit 1 | -7.65 | -7.70 | -7.52 | 20.81% | CHEMBL419399 |
| Oxycodone | NOS1_HUMAN | nitric oxide synthase 1 | -8.49 | -8.68 | -7.68 | 40.78% | CHEMBL42968 |
| TEST | NOS1_HUMAN | nitric oxide synthase 1 | -8.04 | -7.57 | -8.70 | 34.50% | CHEMBL42968 |
| Oxycodone | NOS2_HUMAN | nitric oxide synthase 2 | -7.31 | -8.36 | -9.59 | 40.78% | CHEMBL42968 |
| TEST | NOS2_HUMAN | nitric oxide synthase 2 | -6.89 | -8.84 | -7.90 | 34.50% | CHEMBL42968 |
| Oxycodone | NTRK1_HUMAN | neurotrophic receptor tyrosine kinase 1 | -8.47 | -8.68 | -8.79 | 34.50% | CHEMBL444109 |
| TEST | NTRK1_HUMAN | neurotrophic receptor tyrosine kinase 1 | -7.40 | -8.00 | -7.70 | 39.31% | CHEMBL444109 |
| Oxycodone | OPRD_HUMAN | opioid receptor delta 1 | -8.47 | -6.82 | -7.01 | 99.34% | CHEMBL387016 |
| TEST | OPRD_HUMAN | opioid receptor delta 1 | -7.14 | -6.79 | -7.36 | 100.00% | CHEMBL70 |
| Oxycodone | OPRK_HUMAN | opioid receptor kappa 1 | -9.52 | -9.20 | -7.55 | 99.34% | CHEMBL387016 |
| TEST | OPRK_HUMAN | opioid receptor kappa 1 | -9.06 | -8.55 | -7.70 | 100.00% | CHEMBL70 |
| Oxycodone | OPRM_MOUSE | Mu-type opioid receptor | -8.45 | -8.31 | N/A | 100.00% | CHEMBL656 |
| TEST | OPRM_MOUSE | Mu-type opioid receptor | -8.29 | -8.66 | N/A | 100.00% | CHEMBL70 |
| Oxycodone | OPRX_HUMAN | opioid related nociceptin receptor 1 | -7.70 | -7.01 | -7.59 | 75.93% | CHEMBL511142 |
| TEST | OPRX_HUMAN | opioid related nociceptin receptor 1 | -8.07 | -7.12 | -7.42 | 94.38% | CHEMBL3262362 |
| Oxycodone | P2RX3_HUMAN | purinergic receptor P2X 3 | -6.23 | -5.88 | -6.07 | 36.70% | CHEMBL3679750 |
| TEST | P2RX3_HUMAN | purinergic receptor P2X 3 | -6.39 | -5.93 | -6.38 | 35.47% | CHEMBL3679847 |
| Oxycodone | P2Y12_HUMAN | purinergic receptor P2Y12 | -7.26 | -3.41 | -7.67 | 34.31% | CHEMBL88108 |
| TEST | P2Y12_HUMAN | purinergic receptor P2Y12 | -6.65 | -4.47 | -6.12 | 28.47% | CHEMBL2172277 |
| Oxycodone | PAR1_HUMAN | coagulation factor II thrombin receptor | -9.22 | N/A | N/A | 39.00% | CHEMBL334510 |
| TEST | PAR1_HUMAN | coagulation factor II thrombin receptor | -9.16 | N/A | N/A | 34.35% | CHEMBL3086083 |
| Oxycodone | PDE4B_HUMAN | phosphodiesterase 4B | -8.23 | -8.81 | -9.09 | 57.50% | CHEMBL144499 |
| TEST | PDE4B_HUMAN | phosphodiesterase 4B | -8.01 | -7.41 | -8.38 | 45.95% | CHEMBL144499 |
| Oxycodone | PDE5A_HUMAN | phosphodiesterase 5A | -7.78 | -8.20 | -8.63 | 36.13% | CHEMBL190423 |
| TEST | PDE5A_HUMAN | phosphodiesterase 5A | -7.82 | -8.14 | -8.24 | 31.75% | CHEMBL190423 |
| Oxycodone | PERM_HUMAN | myeloperoxidase | -8.33 | -8.16 | -8.10 | 37.64% | CHEMBL490 |
| TEST | PERM_HUMAN | myeloperoxidase | -7.90 | -7.96 | -8.02 | 35.57% | CHEMBL490 |
| Oxycodone | PGH1_SHEEP | Prostaglandin G/H synthase 1 | -5.89 | -7.94 | -7.43 | 35.45% | CHEMBL24798 |
| TEST | PGH1_SHEEP | Prostaglandin G/H synthase 1 | -3.16 | -7.62 | -7.03 | 34.85% | CHEMBL229957 |
| Oxycodone | PGH2_HUMAN | prostaglandin-endoperoxide synthase 2 | -1.16 | -4.32 | -9.85 | 42.14% | CHEMBL276663 |
| TEST | PGH2_HUMAN | prostaglandin-endoperoxide synthase 2 | 1.36 | -6.24 | -6.70 | 34.92% | CHEMBL13988 |
| Oxycodone | PPAP_HUMAN | acid phosphatase 3 | -7.86 | N/A | N/A | 22.99% | CHEMBL507996 |
| TEST | PPAP_HUMAN | acid phosphatase 3 | -8.39 | N/A | N/A | 20.39% | CHEMBL507996 |
| Oxycodone | PPARG_HUMAN | peroxisome proliferator activated receptor gamma | -7.26 | -6.35 | -7.52 | 47.93% | CHEMBL419756 |
| TEST | PPARG_HUMAN | peroxisome proliferator activated receptor gamma | -6.50 | -5.87 | -6.23 | 43.24% | CHEMBL1836977 |
| Oxycodone | PRGR_HUMAN | progesterone receptor | -6.90 | -6.73 | -8.21 | 40.21% | CHEMBL1911657 |
| TEST | PRGR_HUMAN | progesterone receptor | -9.04 | -9.47 | -8.73 | 40.72% | CHEMBL51933 |
| Oxycodone | PTGES_HUMAN | prostaglandin E synthase | -6.59 | N/A | N/A | 39.60% | CHEMBL538661 |
| TEST | PTGES_HUMAN | prostaglandin E synthase | -6.74 | N/A | N/A | 37.75% | CHEMBL3753433 |
| Oxycodone | SC6A4_HUMAN | solute carrier family 6 member 4 | -9.08 | -8.86 | -8.69 | 52.67% | CHEMBL52440 |
| TEST | SC6A4_HUMAN | solute carrier family 6 member 4 | -9.44 | -9.20 | -9.29 | 46.48% | CHEMBL434728 |
| Oxycodone | SCN9A_HUMAN | sodium voltage-gated channel alpha subunit 9 | -6.27 | N/A | N/A | 42.94% | CHEMBL203440 |
| TEST | SCN9A_HUMAN | sodium voltage-gated channel alpha subunit 9 | -6.25 | N/A | N/A | 40.00% | CHEMBL3662107 |
| Oxycodone | TLR4_HUMAN | toll like receptor 4 | -7.77 | -7.49 | -7.61 | 41.46% | CHEMBL3261030 |
| TEST | TLR4_HUMAN | toll like receptor 4 | -8.26 | -8.29 | -7.17 | 37.84% | CHEMBL3261029 |
| Oxycodone | TNFA_HUMAN | tumor necrosis factor | -7.83 | N/A | N/A | 49.77% | CHEMBL2337619 |
| TEST | TNFA_HUMAN | tumor necrosis factor | -7.88 | N/A | N/A | 54.46% | CHEMBL2337619 |
| Oxycodone | TRBM_HUMAN | thrombomodulin | -7.24 | -7.04 | N/A | N/A | N/A |
| TEST | TRBM_HUMAN | thrombomodulin | -7.23 | -7.14 | N/A | N/A | N/A |
| Oxycodone | TRPM4_HUMAN | transient receptor potential cation channel subfamily M member 4 | -7.59 | -7.06 | N/A | N/A | N/A |
| TEST | TRPM4_HUMAN | transient receptor potential cation channel subfamily M member 4 | -7.73 | -6.69 | N/A | N/A | N/A |
| Oxycodone | TRPM8_FICAL | Uncharacterized protein | -9.00 | N/A | N/A | N/A | N/A |
| TEST | TRPM8_FICAL | Uncharacterized protein | -8.65 | N/A | N/A | N/A | N/A |
| Oxycodone | TRPV1_RAT | Transient receptor potential cation channel subfamily V member 1 | -8.61 | N/A | N/A | 44.51% | CHEMBL2057858 |
| TEST | TRPV1_RAT | Transient receptor potential cation channel subfamily V member 1 | -7.83 | N/A | N/A | 42.71% | CHEMBL97968 |
| Oxycodone | TRPV2_RABIT | Transient receptor potential cation channel subfamily V member 2 | -9.02 | -8.00 | N/A | N/A | N/A |
| TEST | TRPV2_RABIT | Transient receptor potential cation channel subfamily V member 2 | -8.54 | -8.15 | N/A | N/A | N/A |
| Oxycodone | TRPV3_HUMAN | transient receptor potential cation channel subfamily V member 3 | -6.99 | -7.95 | N/A | 50.00% | CHEMBL3664218 |
| TEST | TRPV3_HUMAN | transient receptor potential cation channel subfamily V member 3 | -6.52 | -7.86 | N/A | 44.88% | CHEMBL3664218 |
| Oxycodone | TRXR1_HUMAN | thioredoxin reductase 1 | -8.35 | -7.77 | -6.80 | N/A | N/A |
| TEST | TRXR1_HUMAN | thioredoxin reductase 1 | -8.46 | -8.10 | -7.03 | N/A | N/A |
| Oxycodone | TRY1_HUMAN | serine protease 1 | -6.00 | N/A | N/A | 38.81% | CHEMBL69394 |
| TEST | TRY1_HUMAN | serine protease 1 | -6.01 | N/A | N/A | 33.22% | CHEMBL73970 |